Aubrai
Aubrai32About
What does Aubrai do?
Aubrai is the world's first decentralized scientific agent designed to accelerate longevity research. Co-developed by VitaDAO and Bio Protocol, it leverages AI and blockchain technology to generate and validate research hypotheses, design wet-lab experiments, and protect intellectual property. Aubrai is trained on extensive longevity research data, including unpublished insights from Dr. Aubrey de Grey's lab, and aims to overcome funding gaps in scientific discovery.
What is Aubrai's valuation?
StartupHub estimates Aubrai's effective valuation at $17.8M (range $12.5M to $30.0M, 19% confidence), based on comparable companies in the sector.
How much funding has Aubrai raised?
Aubrai has raised a total of $5M in funding. The most recent round on record is Seed.
What industry does Aubrai operate in?
Aubrai operates in Longevity, AI, Decentralized Science (DeSci), Bioinformatics, Genetic Data Analysis, Foundation Model.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Longevity and metabolic health platform offering personalized insights and interventions.
An AI-native platform that helps individuals plan their entire 100-year life by integrating health, money, work, and purpose.
AI-powered platform for personalized health and longevity.
A free, instant biological-age mirror that tells you how old your body really is, with no signup required.
AI-powered longevity and wellness insights based on aging hallmarks.
An entrant is a company tagged Longevity whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.